Free Access
| Issue |
Med Sci (Paris)
Volume 31, Number 8-9, Août–Septembre 2015
|
|
|---|---|---|
| Page(s) | 728 - 730 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/20153108009 | |
| Published online | 04 September 2015 | |
- Hidalgo M. New insights into pancreatic cancer biology. Ann Oncol 2012 ; 23 : suppl 10 x135–x138. [CrossRef] [PubMed] [Google Scholar]
- Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 2014 ; 14 : 754–762. [CrossRef] [PubMed] [Google Scholar]
- Aguirre AJ, Bardeesy N, Sinha M, et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 2003 ; 17 : 3112–3126. [CrossRef] [PubMed] [Google Scholar]
- Guillaumond F, Leca J, Olivares O, et al. Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proc Natl Acad Sci USA 2013 ; 110 : 3919–3924. [CrossRef] [Google Scholar]
- Bryant KL, Mancias JD, Kimmelman AC, Der CJ KRAS: feeding pancreatic cancer proliferation. Trends Biochem Sci 2014 ; 39 : 91–100. [CrossRef] [PubMed] [Google Scholar]
- Guillaumond F, Bidaut G, Ouaissi M, et al. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma. Proc Natl Acad Sci USA 2015 ; 112 : 2473–2478. [CrossRef] [Google Scholar]
- Hong JY, Nam EM, Lee J, et al. Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients. Cancer Chemother Pharmacol 2014 ; 73 : 125–130. [CrossRef] [PubMed] [Google Scholar]
- Adachi S, Homoto M, Tanaka R, et al. ZFP36L1 and ZFP36L2 control LDLR mRNA stability via the ERK-RSK pathway. Nucleic Acids Res 2014 ; 42 : 10037–10049. [CrossRef] [PubMed] [Google Scholar]
- Zelcer N, Hong C, Boyadjian R, Tontonoz P LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009 ; 325 : 100–104. [CrossRef] [PubMed] [Google Scholar]
- Wang Y, Huang Y, Hobbs HH, Cohen JC Molecular characterization of proprotein convertase subtilisin/kexin type 9-mediated degradation of the LDLR. J Lipid Res 2012 ; 53 : 1932–1943. [CrossRef] [PubMed] [Google Scholar]
- Bournet B, Dufresne M, Selves J, et al. Oncogène Kras et cancer du pancréas : trente ans plus tard. Med Sci (Paris) 2013 ; 29 : 991–997. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.